Brokerages expect Cardinal Health Inc (NYSE:CAH) to report earnings per share (EPS) of $1.08 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Cardinal Health’s earnings. The lowest EPS estimate is $1.01 and the highest is $1.16. Cardinal Health reported earnings per share of $1.09 in the same quarter last year, which indicates a negative year-over-year growth rate of 0.9%. The business is scheduled to report its next quarterly earnings results on Monday, November 5th.
On average, analysts expect that Cardinal Health will report full-year earnings of $5.03 per share for the current financial year, with EPS estimates ranging from $4.96 to $5.15. For the next fiscal year, analysts expect that the company will report earnings of $5.43 per share, with EPS estimates ranging from $5.27 to $5.55. Zacks Investment Research’s earnings per share averages are an average based on a survey of research analysts that that provide coverage for Cardinal Health.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Monday, August 6th. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.08. The business had revenue of $35.35 billion for the quarter, compared to the consensus estimate of $34.38 billion. Cardinal Health had a net margin of 0.19% and a return on equity of 22.59%. Cardinal Health’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period last year, the company posted $1.31 EPS.
A number of equities research analysts have recently weighed in on the company. Zacks Investment Research raised Cardinal Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 3rd. Robert W. Baird reissued a “hold” rating and issued a $51.00 price target on shares of Cardinal Health in a research note on Friday, July 20th. Morgan Stanley lowered their price target on Cardinal Health from $55.00 to $40.00 and set an “underweight” rating for the company in a research report on Tuesday, July 3rd. Royal Bank of Canada restated a “hold” rating and issued a $56.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 7th. Finally, Mizuho reissued a “hold” rating and set a $53.00 price objective on shares of Cardinal Health in a report on Sunday, August 12th. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company. Cardinal Health presently has an average rating of “Hold” and a consensus price target of $62.31.
Shares of CAH traded down $0.02 during mid-day trading on Friday, hitting $55.15. 60,948 shares of the company’s stock were exchanged, compared to its average volume of 2,734,275. Cardinal Health has a 52 week low of $48.14 and a 52 week high of $75.75. The company has a quick ratio of 0.53, a current ratio of 1.07 and a debt-to-equity ratio of 1.32. The stock has a market capitalization of $16.66 billion, a P/E ratio of 11.01, a P/E/G ratio of 1.68 and a beta of 1.04.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Shareholders of record on Monday, October 1st will be given a dividend of $0.4763 per share. This represents a $1.91 annualized dividend and a yield of 3.45%. The ex-dividend date is Friday, September 28th. This is a boost from Cardinal Health’s previous quarterly dividend of $0.48. Cardinal Health’s dividend payout ratio (DPR) is 38.20%.
In other news, CEO Jon L. Giacomin sold 2,890 shares of the firm’s stock in a transaction on Monday, August 20th. The stock was sold at an average price of $51.95, for a total value of $150,135.50. Following the completion of the sale, the chief executive officer now owns 72,652 shares of the company’s stock, valued at approximately $3,774,271.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.97% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Signaturefd LLC acquired a new stake in shares of Cardinal Health during the 1st quarter valued at about $100,000. Optimum Investment Advisors acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $128,000. Mount Yale Investment Advisors LLC acquired a new position in shares of Cardinal Health during the 1st quarter worth approximately $136,000. Sentry Investment Management LLC purchased a new stake in shares of Cardinal Health during the 2nd quarter valued at approximately $132,000. Finally, Archford Capital Strategies LLC purchased a new stake in shares of Cardinal Health during the 1st quarter valued at approximately $174,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Cardinal Health Company Profile
Cardinal Health, Inc operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.